GENSIGHT BIOLOGICS Stock 10.21% Up Before The Weekend
(VIANEWS) – The Market ended the session with GENSIGHT BIOLOGICS (SIGHT.PA) rising 10.21% to €2.40 on Friday while CAC 40 rose 0.81% to €7,322.39. About GENSIGHT BIOLOGICS GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system….